RE:Great News RecapHe also mentioned they are going into a phase (can't remember what it is specifically called) where they are making 200-300 tests a day before they seek FDA approval. That's what it depends on. So here's a reality check for everyone. If Aristotle is legit where THEY ARE releasing it in Q1 2021 with an initiation process before they release it mainstream. Their telepath platform being revolutionary and their competitors being valued over 10 billion combined. SZLS is ahead. The FDA approval holds them back. The risk is yours. Do you believe in the future of cancer testing or you don't like what they are doing. Either way. Make a choice and move on. Stop bashing the board. This is facts not fiction. Lots of great things. One thing holding it back.